anmelden
OMX Stockholm PI
1.062,47
PKT
-15,23
PKT
-1,41
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Stockholm PI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.03.23 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 30.03.23 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. | |
| 30.03.23 | Hennes Mauritz (H M, H&M) Buy | Deutsche Bank AG | |
| 30.03.23 | Hennes Mauritz (H M, H&M) Buy | Deutsche Bank AG | |
| 30.03.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 30.03.23 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 29.03.23 | Nokia Equal Weight | Barclays Capital | |
| 23.03.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 21.03.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 20.03.23 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 20.03.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 16.03.23 | Hennes Mauritz (H M, H&M) Buy | Deutsche Bank AG | |
| 15.03.23 | Hennes Mauritz (H M, H&M) Buy | Deutsche Bank AG | |
| 15.03.23 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 15.03.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 15.03.23 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 15.03.23 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.03.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 13.03.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 10.03.23 | AstraZeneca Neutral | UBS AG | |
| 09.03.23 | Nokia Neutral | UBS AG | |
| 09.03.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.03.23 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 08.03.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 07.03.23 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 07.03.23 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 02.03.23 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 02.03.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 27.02.23 | Nokia Buy | Jefferies & Company Inc. | |
| 27.02.23 | Nokia Buy | Goldman Sachs Group Inc. | |
| 23.02.23 | Nokia Buy | Goldman Sachs Group Inc. | |
| 21.02.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 21.02.23 | AstraZeneca Neutral | UBS AG | |
| 20.02.23 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. | |
| 20.02.23 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 16.02.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 15.02.23 | Nokia Buy | Goldman Sachs Group Inc. | |
| 15.02.23 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 14.02.23 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 14.02.23 | Nokia Outperform | Credit Suisse Group |